stock analyst

May 16, 2024

WUXI APPTEC Strongly Objects to 'Unjustified Designation' by US House Bill, Reiterates No Human Genomics Biz

WUXI APPTEC (02359.HK)  -0.100 (-0.242%)    Short selling $51.31M; Ratio 7.285%   learned that on 15 May 2024, the US House Committee on Oversight and Accountability voted to report to the House a draft bill H.R.8333, which is an amended version of the predecessor bill H.R.7085 for the proposed Biosecure Act. Bill H.R.8333 incorporates certain amendments including, among others, the removal of certain alleged findings against WUXI APPTEC and the addition of a “grandfather” clause that exempts existing contracts entered into before the effectiveness of the proposed restrictions.

Read More
May 16, 2024

<Research>CMBI Cuts TP of Alibaba (BABA.US) to US$124.9, Rates Buy

CMBI highlighted in a report that BABA-SW (09988.HK)  -2.950 (-3.569%)    Short selling $1.05B; Ratio 11.908%   (BABA.US)      achieved a 6.6% YoY growth in revenue for 4FQ24 ended in March this year. Increased investment during the period helped drive improved user experience, GMV growth in domestic business and expansion of international business. Taobao Tmall Group achieved double-digit YoY growth in GMV, international commerce retail revenue hiked 56%, while AI-related cloud business revenue soared by triple digits.

Read More